Propargyl-PEG5-NHS ester

Propargyl-PEG5-NHS ester

Propargyl-PEG5-NHS ester has a propargyl group and an NHS ester group. The terminal NHS ester and is an amine reactive moeity which is useful for derivatizing peptides, antibodies, amine coated surfaces etc. The propargyl group can participate in Click Chemistry reactions with azide compounds, copper is needed for catalyzation. The PEG units can enhance the hydrophilicity of the molecule. Please contact us for GMP-grade inquiries.

Molecular structure of the compound BP-20907
    • Unit
    • Price
    • Qty
    • 100 MG
    • $260.00
    • 500 MG
    • $580.00
    • 1 G
    • $780.00
    • 5 G
    • $1600.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire

Product Citations

  1. Anthony Nicholas, Erik W. Bush, David Itiro Kasahara, Casi M. Schienebeck. Rnai agents for inhibiting expression of receptor for advanced glycation end-products, compositions thereof, and methods of use. (CA3213968A1)
    https://patents.google.com/patent/CA3213968A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=32
  2. Casi SCHIENEBECK, Szymon Klossowski, Tingting YUAN, Tao Pei, Jeffrey Carlson, Agnieszka Glebocka, Mark MAJEWSKI. Rnai agents for inhibiting expression of thymic stromal lymphopoietin (tslp), compositions thereof, and methods of use. (WO2024173520A2)
    https://patents.google.com/patent/WO2024173520A2/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=15
  3. Casi SCHIENEBECK, Zhao XU. Optimized RNAi Agents for Inhibiting Expression of Coronavirus (CoV) Viral Genomes, Compositions Thereof, and Methods of Use. (WO2024163750A2)
    https://patents.google.com/patent/WO2024163750A2/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=15
  4. Christine Esau, Jeffrey Carlson, Anthony Nicholas, Ji Young Suk, Xiaokai Li, Teng Ai. Rnai agents for inhibiting expression of androgen receptor (ar), compositions thereof, and methods of use. (WO2025160224A1)
    https://patents.google.com/patent/WO2025160224A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=3
  5. Christine Esau, Ji Young SUK, Tao Pei, Anthony Nicholas, Xiaokai Li, Jeffrey Carlson. Rnai agents for inhibiting expression of superoxide dismutase 1 (sod1), compositions thereof, and methods of use. (WO2023245060A2)
    https://patents.google.com/patent/WO2023245060A2/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=22
  6. Christine I. Wooddell, Anthony Nicholas, Audra WINTER, Casi SCHIENEBECK, Tao Pei. Rnai agents for inhibiting expression of coronavirus (cov) viral genomes, compositions thereof, and methods of use. (EP4473112A2)
    https://patents.google.com/patent/EP4473112A2/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=25
  7. Erik Bush, Keivan ZANDI, Zhao XU, Tingting YUAN, Alireza SAEIDI, Casi SCHIENEBECK, Anthony Nicholas, Tao Pei. Rnai agents for inhibiting influenza a viral gene expression, compositions thereof, and methods of use. (WO2024151991A1)
    https://patents.google.com/patent/WO2024151991A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=15
  8. Erik W. Bush, Anthony Nicholas, Casi M. Schienebeck. Rnai agents for inhibiting expression of mucin 5ac (muc5ac), compositions thereof, and methods of use. (AU2022280863A1)
    https://patents.google.com/patent/AU2022280863A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=32
  9. Michelle NGAI, Mark MAJEWSKI, Zhi-ming DING, Agnieszka Glebocka, Tao Pei, James Hamilton, Grigoriy SHEKHTMAN. Rnai agents for inhibiting expression of activin receptor-like kinase 7 (alk7), compositions thereof, and methods of use. (WO2025137390A1)
    https://patents.google.com/patent/WO2025137390A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=4
  10. Phillip LAZZARAJi Young SukChristine EsauTao PeiXiaokai LiAgnieszka GlebockaZhao XUJeffrey CarlsonJingdong YeKayal MADHIVANAN. Rnai agents for inhibiting expression of microtubule associated protein tau (mapt), compositions thereof, and methods of use. (WO2025212467A1)
    https://patents.google.com/patent/WO2025212467A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=1
  11. 知永 石, 克莉絲丁 伊索, 李曉愷, 菲利普 樂札瑞, 濤 裴, 安東尼 尼可拉斯, 傑佛瑞 卡爾森, 伊瓦爾 史坦. Rnai agents for inhibiting expression of ataxin-2 (atxn2), compositions thereof, and methods of use. (TW202444390A)
    https://patents.google.com/patent/TW202444390A/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=14
  12. 詹姆士 Ｃ 漢彌頓, 艾瑞克 Ｗ 布希, 大衛 伊提洛 卡撒賀拉, 安東尼 尼可拉斯. Subcutaneous delivery of rnai agents for inhibiting expression of receptor for advanced glycation end-products (rage). (TW202345868A)
    https://patents.google.com/patent/TW202345868A/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=24
  13. 馬克 瑪猶斯基, 安格尼斯卡 葛利波卡, 濤 裴, 強納森 班森, 昭 徐. Lipid conjugates for the delivery of therapeutic agents to adipose tissue. (TW202434200A)
    https://patents.google.com/patent/TW202434200A/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=15
  14. 앤서니 니콜라스, 타오 페이, 에릭 더블유. 부쉬, 팅팅 위안. RNAi agents, compositions thereof, and methods of use for inhibiting expression of matrix metalloproteinase 7 (MMP7). (KR20240099296A)
    https://patents.google.com/patent/KR20240099296A/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=28